SNMMI Curriculum VL

Appropriate Use Criteria for PSMA PET Imaging - Hossein Jadvar

Details
Phillip Koo is joined by Hossein Jadvar to discuss the Appropriate Use Criteria (AUC) for PSMA PET in prostate cancer. Dr. Jadvar, the first author of the publication, discusses the process of developing the AUC for PSMA PET in prostate cancer and reviews 11 clinical scenarios that may be encountered by ordering professionals when they want to consult the AUC for ordering their imaging. To guide r...

Imaging Prostate Cancer with F18 Fluciclovine PET - Neha Maithel & Isis Gayed

Details
In this educational video presentation from the Society of Nuclear Medicine and Molecular Imaging (SNMMI), Drs Neha Maithel and Isis Gayed present on imaging in prostate cancer with a focus on F-18 Axumin® PET. Axumin (fluciclovine F 18) injection is indicated for positron emission tomography (PET) imaging in men with suspected prostate cancer recurrence based on elevated blood prostate specific a...

PSMA-targeted PET Imaging of Prostate Cancer - A Primer for Urologists - Michael Gorin

Details
In this Society of Nuclear Medicine and Molecular Imaging (SNMMI), Satellite Symposium entitled PSMA-Targeted PET Imaging and Interpretation: What Urologists Need to Know Michael Gorin, MD presents on PSMA-targeted PET Imaging of Prostate Cancer - A Primer for Urologists. Dr. Gorin starts with reviewing conventional imaging modalities for prostate cancer which have proved insufficient for detectin...

Symposium Discussion on PSMA-Targeted PET Imaging and Interpretation - What Urologists Need to Know

Details
Following presentations from Micheal Gorin and Steven Rowe during this Society of Nuclear Medicine and Molecular Imaging (SNMMI) Satellite Symposium entitled PSMA-Targeted PET Imaging and Interpretation: What Urologists Need to Know presented in conjunction with the American Urological Association Annual Meeting, the pair engage in a question and answer session. Drs. Gorin and Rowe comment on thei...

PSMA-Targeted PET Imaging Metastatic Disease, Response Assessment, Future Directions, and Read Paradigms - Steven Rowe

Details
In this Society of Nuclear Medicine and Molecular Imaging (SNMMI) Satellite Symposium entitled PSMA-Targeted PET Imaging and Interpretation: What Urologists Need to Know Steven Rowe, MD presents on PSMA-Targeted PET Imaging: Metastatic Disease, Response Assessment, Future Directions, and Read Paradigms. In his talk, he focuses on PSMA PET imaging in the context of metastatic disease, both small vo...

Radium-223 Treatment for Metastatic Prostate Cancer - Ila Sethi

Details
As part of this patient-centered video series of lectures on prostate cancer diagnosis and treatment, Dr Sethi presents the timing for radium-223 treatment in mCRPC. She details who qualifies as a candidate for radium 223 therapy, how it is given, the limited side effects of this treatment, that PSA is not a biomarker for treatment success and other treatment management considerations. Biography:...

Imaging With Fluciclovine for Prostate Cancer - Bital Savir-Baruch

Details
In this educational video from the Society of Nuclear Medicine and Molecular Imaging (SNMMI), Dr Bital Savir-Baruch, a nuclear medicine physician from Loyola University Medical Center, covers the limitation of conventional imaging for localized prostate cancer sites in patients with suspected disease recurrence, and the role of fluciclovine PET CT imaging in prostate cancer recurrence. Biographies...

PSMA Theranostics in Prostate Cancer SNMMI - Richard Baum

Details
In this lecture, Richard Baum presents the development and practices of the Theranostic Imaging Center in Bad Berka, Germany where he focuses on the use of screening methods to promote "precision oncology". He highlights the use of prostate-specific membrane antigen (PSMA) for prostate cancer. Imaging for PSMA allows doctors to properly assign patients to therapy responses using predictive measure...

Discussion from Changing the Standard of Care in Prostate Cancer with Advances in Nuclear Medicine, PET and Theranostics Symposium

Details
Rob Flavell moderates the Question and Answer session in this closing module of the Prostate Cancer Outreach Webinar - Hosted by The Society of Nuclear Medicine and Molecular Imaging (SNMMI) Prostate Cancer Working Group and University of California San Francisco (UCSF). This Question and Answer session follows presentations by Tom Hope, Hao Nguyen, Felix Feng, and Rahul Aggarwal on nuclear medici...

PSMA-Based Diagnostic and Theranostic Strategies in Metastatic Prostate Cancer - Rahul Aggarwal

Details
This webinar organized in collaboration with The Society of Nuclear Medicine and Molecular Imaging (SNMMI)'s Prostate Cancer Working Group, and faculty from the University of California, San Francisco (UCSF), Rahul Aggarwal, MD presents on PSMA-based diagnostic and theranostic strategies in metastatic prostate cancer. Biographies: Rahul Aggarwal, MD Assistant Professor of Hematology/Oncology, Dire...
email news signup